PAPER Duzel E, Schöttler M, Sommer H, Griebe M

Protocol: Prospective evaluation of feasibility, added value and satisfaction of remote digital self-assessment for mild cognitive impairment in routine care with the neotivCare app.

BMJ Open. 2024 Mar 12;14(3):e081159. PubMed.

PAPER Ozsurekci C, Satis NK, Demircan SK, Naharci MI

Association of Anticholinergic Drug Burden With Cognitive and Functional Decline Over Time in Dementia With Lewy Bodies: 1-Year Follow-Up Study.

Clin Neuropharmacol. 2024 Mar-Apr 01;47(2):48-53. PubMed.

PAPER Alosco ML, Tartaglia MC

Repetitive Blast Injury and CSF Alzheimer Disease Biomarkers: Navigating a Complex Narrative.

Neurology. 2024 Apr 9;102(7):e209294. Epub 2024 Mar 13 PubMed.

PAPER Li G, Iliff J, Shofer J, Mayer CL, Meabon J, Cook D, Pagulayan KF, Raskind MA, Zetterberg H, Blennow K, Peskind ER

CSF β-Amyloid and Tau Biomarker Changes in Veterans With Mild Traumatic Brain Injury.

Neurology. 2024 Apr 9;102(7):e209197. Epub 2024 Mar 13 PubMed.

PAPER Scekic-Zahirovic J, Benetton C, Brunet A, Ye X, Logunov E, Douchamps V, Megat S, Andry V, Kan VW, Stuart-Lopez G, Gilet J, Guillot SJ, Dirrig-Grosch S, Gorin C, Trombini M, Dieterle S, Sinniger J, Fischer M, René F, Gunes Z, Kessler P, Dupuis L, Pradat PF, Goumon Y, Goutagny R, Marchand-Pauvert V, Liebscher S, Rouaux C

Cortical hyperexcitability in mouse models and patients with amyotrophic lateral sclerosis is linked to noradrenaline deficiency.

Sci Transl Med. 2024 Mar 13;16(738):eadg3665. PubMed.

PAPER Marques C, Held A, Dorfman K, Sung J, Song C, Kavuturu AS, Aguilar C, Russo T, Oakley DH, Albers MW, Hyman BT, Petrucelli L, Lagier-Tourenne C, Wainger BJ

Neuronal STING activation in amyotrophic lateral sclerosis and frontotemporal dementia.

Acta Neuropathol. 2024 Mar 13;147(1):56. PubMed.

PAPER Rai P, Sundarakumar JS, Basavaraju N, Kommaddi RP, Issac TG

Association between ApoE ε4 genotype and attentional function in non-demented, middle-aged, and older adults from rural India.

J Neurosci Rural Pract. 2024;15(1):117-125. Epub 2024 Jan 9 PubMed.

PAPER Wasielewska JM, Szostak K, McInnes LE, Quek H, Chaves JC, Liddell JR, Koistinaho J, Oikari LE, Donnelly PS, White AR

Patient-Derived Blood-Brain Barrier Model for Screening Copper Bis(thiosemicarbazone) Complexes as Potential Therapeutics in Alzheimer's Disease.

ACS Chem Neurosci. 2024 Apr 3;15(7):1432-1455. Epub 2024 Mar 13 PubMed.

PAPER Katariya RA, Sammeta SS, Kale MB, Kotagale NR, Umekar MJ, Taksande BG

Agmatine as a novel intervention for Alzheimer's disease: Pathological insights and cognitive benefits.

Ageing Res Rev. 2024 Apr;96:102269. Epub 2024 Mar 11 PubMed.

PAPER Muroni A, Floris G, Borghero G, Ardu S, Pateri MI, Pilotto S, Pisano G, Defazio G

Point prevalence of epilepsy in dementia: A "real-world" estimate.

Epileptic Disord. 2024 Apr;26(2):209-214. Epub 2024 Mar 13 PubMed.

PAPER Mansuri S, Jain A, Singh R, Rawat S, Mondal D, Raychaudhuri S

Widespread nuclear lamina injuries defeat proteostatic purposes of α-synuclein amyloid inclusions.

J Cell Sci. 2024 Apr 1;137(7) Epub 2024 Apr 16 PubMed.

PAPER Biesbroek JM, Coenen M, DeCarli C, Fletcher EM, Maillard PM, Alzheimer's Disease Neuroimaging Initiative, Barkhof F, Barnes J, Benke T, Chen CP, Dal-Bianco P, Dewenter A, Duering M, Enzinger C, Ewers M, Exalto LG, Franzmeier N, Hilal S, Hofer E, Koek HL, Maier AB, McCreary CR, Papma JM, Paterson RW, Pijnenburg YA, Rubinski A, Schmidt R, Schott JM, Slattery CF, Smith EE, Sudre CH, Steketee RM, Teunissen CE, van den Berg E, van der Flier WM, Venketasubramanian N, Venkatraghavan V, Vernooij MW, Wolters FJ, Xin X, Kuijf HJ, Biessels GJ

Amyloid pathology and vascular risk are associated with distinct patterns of cerebral white matter hyperintensities: A multicenter study in 3132 memory clinic patients.

Alzheimers Dement. 2024 Apr;20(4):2980-2989. Epub 2024 Mar 13 PubMed.

PAPER Howard R, Cort E, Rawlinson C, Wiegand M, Downey A, Lawrence V, Banerjee S, Bentham P, Fox C, Harwood R, Hunter R, Livingston G, Moniz-Cook E, Panca M, Raczek M, Ivenso C, Russell G, Thomas A, Wilkinson P, Freemantle N, Gould R

Adapted problem adaptation therapy for depression in mild to moderate Alzheimer's disease dementia: A randomized controlled trial.

Alzheimers Dement. 2024 Apr;20(4):2990-2999. Epub 2024 Mar 13 PubMed.

PAPER Mekkes NJ, Groot M, Hoekstra E, de Boer A, Dagkesamanskaia E, Bouwman S, Wehrens SM, Herbert MK, Wever DD, Rozemuller A, Eggen BJ, Huitinga I, Holtman IR

Identification of clinical disease trajectories in neurodegenerative disorders with natural language processing.

Nat Med. 2024 Apr;30(4):1143-1153. Epub 2024 Mar 12 PubMed.

PAPER Tolar M, Hey JA, Power A, Abushakra S

The Single Toxin Origin of Alzheimer's Disease and Other Neurodegenerative Disorders Enables Targeted Approach to Treatment and Prevention.

Int J Mol Sci. 2024 Feb 27;25(5) PubMed.